Unilever Confirms Ice Cream Demerger on Track Amid Resilient Q1 2025 Performance

Unilever Scoops Up Resilience While Prepping Magnum for Independence

Let’s cut through the financial frost: Unilever’s Q1 2025 results show a consumer goods giant navigating choppy waters with one hand while deftly preparing to spin off its ice cream empire with the other. Here’s what investors need to know.

The Headline Scoop

A 3% underlying sales growth (USG) tells us Unilever isn’t melting under pressure. But dig deeper and you’ll find fascinating contrasts:

• Premiumisation pays: Power Brands like Dove (+8%) and Vaseline drove growth, proving consumers will pay up for perceived quality
• Geographic split: Developed markets grew 4.5% (third straight quarter above 4%), while emerging markets limped at 2%
• Price vs volume tango: 1.7% price growth + 1.3% volume growth = carefully balanced act in inflationary times

The Ice Cream Plot Thickens

All systems go for the Magnum Ice Cream Company’s Q4 demerger. The numbers suggest they’re exiting on a high note:

• 4% USG in Q1, outperforming group average
• Premium innovations like Magnum Utopia range and Ben & Jerry’s shareable tubs driving margins
• Triple listing (Amsterdam/London/NY) maintains global shareholder base

But here’s the billion-euro question: Can a standalone ice cream business weather commodity price swings without Unilever’s diversified portfolio? September’s Capital Markets Day will be crucial for answers.

Productivity: The Silent Growth Engine

While markets obsess over spin-offs, Unilever’s quietly executing a €800m efficiency play:

• 6,000 jobs cut already (75% of target)
• €550m savings expected by year-end
• Restructuring costs contained at 1.4% of turnover

This isn’t just cost-cutting – it’s fundamental restructuring. The sales force divisionalisation across top 24 markets suggests a leaner, more category-focused operation post-demerger.

Regional Hotspots (and Cold Spots)

North America Shines

6.2% USG proves the portfolio overhaul works. Whole-body deodorants and premium skincare serums aren’t just marketing fluff – they’re moving the needle.

Asia’s Mixed Bag

China’s high-single digit decline and Indonesia’s -6.6% slump raise eyebrows. But management’s betting big on:

• Direct-to-consumer models in China
• Pricing corrections in Indonesia
• Horlicks’ reformulation in India

If these bets pay off, H2 could see emerging markets rebound sharply.

Capital Allocation: Sweetening the Deal

Unilever’s playing 4D chess with its balance sheet:

• €1.5bn buyback underway (H1 completion)
• Dividend up 6.1% – confidence or sugar rush?
• Strategic M&A continues (acquiring Wild, ditching Vegetarian Butcher)

The message is clear: We’re not just surviving separation – we’re thriving through it.

The Road Ahead

With full-year guidance maintained (3-5% USG, margin improvement), Unilever’s walking a tightrope between:

• Premium innovation vs mass-market reach
• Emerging market recovery vs developed market saturation
• Ice Cream independence vs portfolio coherence

Key dates for your diary: 9 September’s Magnum Capital Markets Day could be the investment event of the summer – expect detailed margin targets and growth strategies for the standalone biz.

Final Thought

This isn’t your grandfather’s Unilever. The 135-year-old giant is proving it can churn out consistent growth while radically reshaping its identity. As the Ice Cream division prepares to skate off on its own, investors will be watching to see if the remaining business can maintain its premiumisation momentum without its coolest asset.